Skip to main content
logo
Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
28.03
-0.36 (-1.27%)
Nov 2, 2026, 10:16 AM EST - Market open

Zenas BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1,8271,949342--
Market Cap Growth
21.86%469.46%---
Enterprise Value
1,4821,659-44--
Last Close Price
28.3936.318.19--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
1850.37194.9168.45--
PB Ratio
7.288.051.10--
P/TBV Ratio
7.498.051.10--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
1505.10165.90---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
1.210.010.000.870.03
Net Debt / Equity Ratio
-1.40-1.41-1.12-1.47-1.37
Net Debt / EBITDA Ratio
1.261.622.141.320.87
Net Debt / FCF Ratio
1.531.982.921.171.00
Asset Turnover
0.000.030.020.70-
Quick Ratio
9.785.506.162.442.59
Current Ratio
9.935.616.212.572.64
Return on Equity (ROE)
-199.04%-136.22%-93.22%-102.89%-
Return on Assets (ROA)
-34.42%-35.06%-46.76%-23.77%-
Return on Capital Employed (ROCE)
-43.10%-65.90%-52.40%-60.40%-154.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-32.29%-19.38%-45.87%--
FCF Yield
-12.21%-8.84%-35.00%--
Buyback Yield / Dilution
-60.52%-238.89%-762.01%-2.61%-
SEC Filings: 10-K · 10-Q